RUNX3 functions as an oncogene in ovarian cancer
| Data(s) |
01/08/2011
|
|---|---|
| Resumo |
The Runt domain transcription factor, RUNX3, has been shown to be a tumor suppressor in a variety of cancers including gastric, colon and breast cancer. Interestingly, an oncogenic role for RUNX3 has also been suggested in basal cell carcinoma and head and neck cancer. Here, we explore the role of RUNX3 in ovarian cancer. |
| Identificador | |
| Idioma(s) |
eng |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Lee , C W L , Chuang , L S H , Kimura , S , Lai , S K , Ong , C W , Yan , B , Salto-Tellez , M , Choolani , M & Ito , Y 2011 , ' RUNX3 functions as an oncogene in ovarian cancer ' Gynecologic Oncology , vol 122 , no. 2 , pp. 410-7 . DOI: 10.1016/j.ygyno.2011.04.044 |
| Palavras-Chave | #Gene Expression Profiling #Ovarian Neoplasms #Oncogenes #Humans #Core Binding Factor Alpha 3 Subunit #Cell Line, Tumor #Female |
| Tipo |
article |
